Wildcat Capital Management, LLC Kronos Bio, Inc. Transaction History

Wildcat Capital Management, LLC

  • $152 Million
  • Q2 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
BUY
$1.24 - $1.92 $1.61 Million - $2.49 Million
1,297,959 New
1,297,959 $2.23 Million
Q1 2023

May 12, 2023
SELL
$1.34 - $2.62 $187,965 - $367,515
-140,273 Reduced 9.75%
1,297,959 $1.9 Million
Q4 2020

Feb 12, 2021
BUY
$26.68 - $38.23 $38.4 Million - $55 Million
1,438,232 New
1,438,232 $43 Million

Others Institutions Holding KRON

# of Institutions
5
Shares Held
889K
Call Options Held
0
Put Options Held
0
View Full List

About Kronos Bio, Inc.

KRON Quotes by TradingView
  • Ticker KRON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,769,100
  • Market Cap $50M
  • Description
  • Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...
More about KRON
Track This Portfolio

Track Wildcat Capital Management, LLC Portfolio

Follow Wildcat Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wildcat Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wildcat Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email